Three key considerations for deploying technology to help increase diversity in trials.
Kelly FitzGerald, PhD, CIP
Advertisement
IRB Executive Chair and Vice President, IBC Affairs, WCG
Articles by Kelly FitzGerald, PhD, CIP
Best practices in data re-identification and control when designing future trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Adaptive Trial Design as a Pathway to Faster Development
3
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
4
Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
